Biotalys Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Carlo Boutton
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.2yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 5.8yrs |
Recent management updates
Recent updates
BTLS: Regulatory Momentum For Biofungicide Approvals Will Drive Future Upside Potential
Analysts have adjusted their fair value estimate for Biotalys from €6.70 to €5.03. This reflects updated assumptions on the discount rate, revenue growth, profit margins and future P/E multiples.
Regulatory Delays And Cost Uncertainty Will Test Biological Crop Protection Potential
Catalysts About Biotalys Biotalys develops protein based biocontrol products for crop protection, focused on biofungicides and bioinsecticides. What are the underlying business or industry changes driving this perspective?
Regulatory Tailwinds And Partnerships Will Position Protein Biocontrol Platform For Significant Future Adoption
Catalysts About Biotalys Biotalys develops protein based biocontrol solutions for crop protection using its AGROBODY platform. What are the underlying business or industry changes driving this perspective?Protein Based Biocontrol Platform Will Benefit From Regulatory Tailwinds And Long Term Industry Demand
Catalysts About Biotalys Biotalys develops protein based precision biocontrol products for crop protection across fungicide and insecticide markets. What are the underlying business or industry changes driving this perspective?Does Biotalys (EBR:BTLS) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...CEO
Carlo Boutton
Dr. Carlo Boutton serves as Chief Scientific Officer at Biotalys NV since May 03, 2022 and is its Interim CEO since March 17, 2026. Dr. Boutton held various scientific leadership roles at Ablynx (now Sanof...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman | 5.3yrs | €92.84k | no data | |
| Non-Executive Director | 7.5yrs | no data | no data | |
| Independent Non-Executive Director | 13.5yrs | €59.54k | no data | |
| Chairman of Scientific Advisory Board | 6.3yrs | no data | no data | |
| Non Executive Independent Director | 4.1yrs | €61.53k | no data | |
| Member of the Scientific Advisory Board | 6.3yrs | no data | no data | |
| Member of the Scientific Advisory Board | 6.3yrs | no data | no data | |
| Member of Scientific Advisory Committee | 3.6yrs | no data | no data | |
| Non-Executive Director | 2.8yrs | no data | no data | |
| Director | 1.3yrs | €38.13k | no data |
Experienced Board: BTLS's board of directors are considered experienced (5.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/05 20:21 |
| End of Day Share Price | 2026/07/03 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biotalys NV is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sebastian Bray | Berenberg |
| David Seynnaeve | Degroof Petercam Sponsored Research |
| Guy Sips | KBC Securities NV |